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I.	  Abstract	  An	  increase	  in	  Vitamin	  C,	  E,	  and	  Carotenoids	  have	  been	  associated	  with	  lower	  risks	  of	  cardiovascular	  disease	  because	  of	  their	  ability	  to	  act	  as	  antioxidants.	  	  These	  vitamins	  work	  to	  inhibit	  the	  oxidation	  of	  low-­‐density	  lipoprotein	  (LDL)	  cholesterol,	  which	  plays	  an	  important	  role	  in	  plaque	  formation	  in	  major	  blood	  vessels.	  	  In	  the	  current	  study,	  we	  compared	  the	  dietary	  intake	  of	  Vitamins	  E,	  C,	  and	  Carotenoid	  	  with	  lipids,	  lipoprotein,	  insulin	  sensitivity,	  body	  weight,	  and	  inflammation	  in	  overweight/obese	  African	  Americans	  (AA)	  and	  Whites	  Americans	  (WA)	  with	  dysglycemia.	  The	  purpose	  of	  this	  study	  was	  to	  examine	  the	  relationship	  between	  these	  dietary	  vitamins	  and	  the	  risk	  of	  cardiovascular	  disease	  in	  overweight/obese	  dysglycemic	  subjects,	  as	  well	  as	  examine	  these	  differences	  with	  regards	  to	  the	  race	  of	  the	  subjects.	  In	  our	  study,	  subjects	  were	  24	  WA	  (Mean	  age=	  43±	  14	  years,	  mean	  BMI	  37	  ±5	  kg/m2,	  mean	  BP	  129/79)	  and	  25	  AA	  (Mean	  age=	  45±9	  years,	  mean	  BMI	  38±6	  kg/m2,	  mean	  BP	  127/81).	  	  All	  subjects	  were	  placed	  on	  a	  diet-­‐induced	  weight	  loss	  program	  (Slimfast	  3-­‐2-­‐1)	  for	  6	  months,	  and	  attended	  a	  program	  that	  included	  nutrition	  and	  lifestyle	  changes	  education.	  Subjects	  completed	  a	  food	  frequency	  questionnaire	  (FFQ)	  (Viocare	  Inc.),	  which	  compiled	  their	  nutrient	  intake	  over	  the	  past	  3	  months.	  Standard	  oral	  glucose	  tolerance	  tests	  (fasting	  and	  2-­‐hour	  glucose	  and	  insulin)	  were	  completed	  by	  all	  subjects.	  	  In	  addition,	  fasting	  blood	  levels	  for	  cholesterol,	  HDL-­‐C,	  LDL-­‐C,	  triglycerides,	  Apo	  A-­‐1,	  ApoB,	  CRP,	  and	  oxidized	  LDL	  were	  obtained.	  	  Insulin	  Resistance	  was	  measured	  by	  homeostatic	  model	  assessment	  (HOMA-­‐IR).	  Results	  indicated	  a	  significant	  increase	  in	  Vitamin	  E	  intake	  in	  WA	  and	  a	  significant	  increase	  in	  Vitamin	  E,	  C,	  and	  Carotenoids	  in	  AA	  over	  a	  6	  month	  period.	  	  We	  found	  no	  significant	  changes	  in	  HDL-­‐C,	  LDL-­‐C,	  oxidized	  LDL,	  or	  CRP	  in	  our	  groups.	  There	  were	  significant	  differences	  in	  systolic	  blood	  pressure,	  pulse,	  and	  waist	  circumference	  between	  AA	  and	  WA.	  Based	  on	  the	  RDI,	  the	  mean	  intake	  of	  Vitamin	  C,	  E,	  and	  Carotenoids	  were	  within	  the	  normal	  range	  of	  the	  general	  population’s	  intake	  at	  the	  beginning	  of	  the	  study,	  and	  above	  the	  normal	  range	  after	  6	  months.	  Further	  studies	  are	  warranted	  to	  examine	  this	  relationship	  between	  dietary	  intake	  of	  antioxidants	  and	  their	  ability	  to	  lower	  cardiovascular	  disease	  risk.	  	  	  
	   4	  
	  
II.	  Introduction	  	   It	  is	  well	  known	  that	  cardiovascular	  disease	  is	  the	  leading	  cause	  of	  death	  in	  the	  United	  States,	  with	  1	  in	  3	  Americans	  having	  the	  disease,	  and	  accounting	  for	  36.3%	  of	  deaths	  in	  America—accounting	  for	  more	  deaths	  than	  any	  other	  cause	  [1].	  	  While	  some	  of	  the	  risks	  for	  developing	  cardiovascular	  disease	  can	  be	  attributed	  to	  genetic	  factors,	  many	  are	  influenced	  by	  dietary	  or	  lifestyle	  factors,	  and	  are	  therefore	  able	  to	  be	  modified	  to	  reduce	  cardiovascular	  disease	  risk.	  	  Among	  these	  factors	  that	  can	  be	  modified	  are	  diet,	  physical	  activity,	  and	  body	  weight.	  	  These	  factors	  can	  also	  modify	  high	  blood	  pressure,	  diabetes	  mellitus,	  high	  blood	  cholesterol,	  and	  obesity,	  all	  of	  which	  are	  associated	  with	  cardiovascular	  disease.	  	  In	  the	  general	  population,	  overweight	  is	  defined	  as	  a	  BMI	  of	  25.0	  to	  29.9	  kg/m2,	  and	  obesity	  is	  defined	  as	  a	  BMI	  ≥	  30.0	  kg/m2	  [2].	  	  According	  to	  an	  National	  Health	  and	  Nutrition	  Examination	  Survey	  (NHANES)	  study,	  65%	  of	  U.S.	  adults	  are	  either	  overweight	  or	  obese.	  	  Obesity	  is	  associated	  with	  other	  cardiovascular	  disease	  risk	  factors	  including	  increased	  hypertension,	  glucose	  intolerance,	  and	  increased	  inflammation.	  	  Recent	  studies	  have	  also	  shown	  an	  increased	  correlation	  between	  obesity	  and	  metabolic	  syndrome	  [2].	  	  	  Metabolic	  syndrome	  is	  a	  combination	  of	  physical	  and	  physiological	  abnormalities	  such	  as	  large	  waist	  circumference,	  high	  triglyceride	  levels,	  and	  low	  high-­‐density	  lipoprotein	  (HDL)	  levels	  [3].	  	  Metabolic	  Syndrome	  has	  been	  linked	  with	  increased	  oxidative	  stress	  and	  inflammatory	  markers,	  such	  as	  CRP	  and	  oxidized	  LDL,	  typically	  associated	  with	  cardiovascular	  disease	  [4].	  	  A	  NHANES	  study	  looking	  at	  metabolic	  syndrome	  and	  antioxidants	  found	  that	  lower	  concentrations	  of	  Vitamin	  C	  and	  Carotenoids	  were	  associated	  with	  an	  increase	  in	  metabolic	  syndrome	  criteria	  when	  compared	  to	  subjects	  that	  did	  not	  have	  any	  of	  the	  criteria	  for	  metabolic	  syndrome.	  	  [5].	  	  Higher	  intake	  of	  fruits	  and	  vegetables	  are	  also	  correlated	  with	  a	  lower	  risk	  of	  metabolic	  syndrome	  [6].	  	  	   Cardiovascular	  disease	  involves	  the	  process	  of	  atherosclerosis,	  which	  is	  the	  buildup	  of	  plaque	  on	  the	  walls	  of	  major	  arteries.	  	  On	  a	  microscopic	  level,	  a	  major	  factor	  in	  the	  development	  of	  atherosclerosis	  is	  the	  oxidation	  of	  low-­‐density	  lipoprotein	  (LDL)	  cholesterol.	  	  Once	  the	  LDL	  cholesterol	  becomes	  oxidized,	  it	  moves	  
	   5	  
to	  the	  endothelial	  lining	  of	  a	  major	  artery,	  and	  begins	  to	  start	  accumulating	  many	  inflammatory	  cells	  to	  the	  artery.	  	  The	  accumulation	  of	  these	  inflammatory	  cells	  to	  the	  damaged	  artery	  forms	  fatty	  streaks	  that	  lead	  to	  atherosclerotic	  plaque	  that	  can	  start	  to	  restrict	  blood	  flow	  and	  eventually	  cause	  a	  heart	  attack.	  	  Reactive	  oxygen	  species	  are	  partly	  responsible	  for	  this	  LDL	  oxidation.	  	  These	  oxidation	  events	  may	  be	  inhibited	  by	  antioxidants.	  	  These	  antioxidants	  can	  be	  introduced	  into	  the	  diet	  by	  increasing	  fruit	  and	  vegetable	  intake	  [7]	  or	  through	  the	  supplementation	  of	  vitamins	  that	  act	  as	  antioxidants,	  such	  as	  vitamin	  A,	  vitamin	  C,	  and	  Carotenoids.	  	  	   Higher	  intake	  of	  vitamins	  E,	  C,	  and	  Carotenoids	  are	  typically	  associated	  with	  decreased	  risk	  of	  cardiovascular	  disease	  [8].	  	  These	  vitamins	  work	  as	  antioxidants	  through	  their	  mechanism	  of	  scavenging	  free	  radicals	  and	  other	  oxidative	  species	  before	  they	  can	  initiate	  oxidation	  of	  LDL	  cholesterol.	  	  Each	  of	  these	  vitamins	  have	  a	  different	  mechanism	  that	  achieve	  the	  same	  function	  of	  preventing	  this	  oxidation.	  	  Vitamin	  E	  terminates	  free	  radicals	  by	  scavenging	  peroxyl	  radicals	  [9].	  	  This	  inhibits	  the	  propagation	  of	  free	  radicals	  in	  plasma	  lipoproteins	  and	  membranes	  [10].	  	  Vitamin	  E	  also	  works	  with	  Vitamin	  C	  to	  maintain	  a	  proper	  antioxidant	  and	  free	  radical	  balance	  [10].	  Vitamin	  C	  acts	  as	  a	  reactive	  oxygen	  species	  scavenger	  by	  donating	  an	  electron	  to	  the	  species	  before	  it	  can	  oxidize	  another	  molecule	  [12].	  	  Carotenoids	  such	  as	  lycopene	  and	  xanthophyll	  also	  work	  to	  reduce	  the	  reactive	  oxygen	  species,	  thus	  protecting	  the	  LDL	  cholesterol	  from	  oxidation.	  	  [13].	  	  It	  is	  because	  of	  these	  functions	  that	  the	  American	  Heart	  Association	  Science	  Advisory	  committee	  recommended	  a	  diet	  containing	  antioxidant-­‐rich	  whole	  fruits	  and	  vegetables	  to	  help	  prevent	  cardiovascular	  disease	  [14].	  	   While	  in	  theory,	  the	  ability	  of	  these	  antioxidant	  vitamins	  to	  protect	  LDL	  cholesterol	  from	  oxidation,	  results	  from	  recent	  studies	  have	  demonstrated	  unclear	  and	  varying	  results.	  	  A	  2002	  follow	  up	  study	  from	  the	  National	  Health	  and	  Nutrition	  Examination	  Survey	  found	  decreased	  cardiovascular	  disease	  mortality	  with	  an	  intake	  of	  3	  servings	  of	  fruits	  and	  vegetables	  per	  day.	  	  The	  study	  also	  stated	  that	  the	  roles	  of	  these	  vitamins	  may	  be	  enhanced	  by	  the	  other	  components	  present	  in	  whole	  foods	  [15].	  	  An	  additional	  study	  confirmed	  the	  inverse	  correlation	  between	  antioxidant	  containing	  fruit	  and	  vegetable	  intake	  with	  the	  risk	  of	  cardiovascular	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disease	  in	  healthy	  subjects.	  	  This	  study	  concluded	  that	  having	  various	  cardiovascular	  disease	  risk	  factors,	  such	  as	  diabetes	  or	  hypertension,	  could	  lead	  to	  a	  reduced	  intake	  of	  the	  antioxidants	  and	  mask	  associations	  between	  intake	  and	  cardiovascular	  disease	  risk	  [16].	  While	  this	  study	  showed	  a	  positive	  effect	  of	  vitamins’	  role	  in	  protecting	  against	  cardiovascular	  disease,	  many	  other	  studies—especially	  those	  involving	  vitamin	  supplementation—have	  not	  shown	  significant	  correlations	  between	  these	  vitamins	  and	  cardiovascular	  disease	  [7,14,18].	  	  A	  2011	  study	  involving	  Vitamin	  C	  concluded	  that	  Vitamin	  C	  supplementation	  was	  not	  associated	  with	  decreased	  cardiovascular	  disease	  or	  major	  cardiovascular	  events	  in	  subjects	  who	  were	  already	  at	  high	  risk	  for	  cardiovascular	  disease	  and	  who	  had	  already	  had	  heart	  attacks	  [17].	  	  These	  vitamins	  in	  supplement	  form	  have	  also	  been	  shown	  to	  have	  limited	  effects	  on	  the	  oxidation	  of	  LDL	  cholesterol,	  but	  have	  had	  some	  effects	  subjects	  get	  their	  vitamins	  from	  whole	  foods	  rather	  than	  supplements	  [7,14,18].	  	  	  This	  suggests	  that	  there	  are	  multiple	  factors	  associated	  with	  cardiovascular	  disease	  risk,	  such	  as	  absorption,	  and	  healthy	  versus	  at	  risk	  subjects.	  	  Therefore,	  further	  studies	  are	  warranted.	  	  	   African	  Americans	  have	  been	  typically	  shown	  to	  have	  a	  higher	  risk	  of	  cardiovascular	  disease	  than	  the	  general	  population,	  despite	  having	  higher	  high-­‐density	  lipoprotein	  cholesterol	  levels	  and	  lower	  triglyceride	  levels	  when	  compared	  to	  WA	  [19].	  	  While	  differences	  in	  vitamin	  intake	  has	  not	  been	  found	  between	  AA	  and	  WA,	  various	  biomarkers	  for	  cardiovascular	  disease	  have	  shown	  differences	  in	  response	  to	  vitamin	  intake.	  	  For	  example,	  a	  decrease	  in	  Carotenoid	  intake	  were	  associated	  with	  an	  increase	  in	  insulin	  resistance	  in	  African	  Americans	  but	  not	  in	  whites	  [20].	  	  Even	  though	  these	  findings	  indicate	  differences,	  the	  reason	  behind	  the	  increased	  risk	  still	  remains	  unclear.	  	  
Purpose	  	   The	  purpose	  of	  this	  study	  was	  examine	  changes	  in	  anthropometric	  values,	  vitamin	  intake,	  lipid	  and	  lipoprotein	  levels,	  inflammatory	  markers,	  glucose	  metabolism,	  and	  insulin	  resistance	  in	  response	  to	  a	  6	  month	  diet-­‐induced	  weight	  loss	  study	  among	  AA	  and	  WA.	  	  This	  study	  also	  examined	  ethnic	  differences	  among	  these	  groups.	  	  
	   7	  
	  
III.	  Methods	  	  
III.1	  Antropometrics	  Subjects	  general	  anthropometric	  and	  body	  composition	  measurements	  were	  taken	  over	  the	  6	  month	  period.	  	  The	  measurements	  included	  height	  (in	  cm	  with	  shoes	  off),	  weight	  (in	  kg),	  BMI	  (calculated	  from	  height	  and	  weight),	  waist	  circumference,	  blood	  pressure,	  and	  pulse.	  	  Their	  blood	  pressure	  was	  taken	  by	  an	  Omron	  Blood	  Pressure	  Monitor	  [24]	  while	  the	  subjects	  were	  sitting	  down,	  after	  resting	  for	  10	  minutes.	  	  	  
III.2	  Food	  Recall	  Subjects	  completed	  a	  food	  frequency	  questionnaire	  (23],	  which	  compiled	  their	  general	  nutrient	  intake	  over	  the	  past	  3	  months.	  	  The	  Viocare	  food	  frequency	  questionnaire	  (FFQ)	  involved	  selecting	  food	  from	  a	  general	  list	  (i.e.	  cold	  breakfast	  cereals	  or	  corn	  tortillas),	  and	  indicating	  how	  many	  times	  over	  the	  past	  3	  months	  those	  foods	  were	  eaten.	  	  The	  FFQ	  calculated	  their	  carbohydrate,	  protein,	  fat,	  and	  vitamin	  intake	  based	  on	  their	  answers.	  	  This	  was	  completed	  at	  baseline	  and	  6	  months	  of	  the	  study.	  	  
III.3	  Metabolic	  Studies	  Standard	  Oral	  Glucose	  Tolerance	  tests	  (glucose	  and	  insulin)	  were	  performed	  at	  the	  baseline	  and	  6	  month	  mark.	  Fasting	  and	  2-­‐hour	  glucose	  and	  insulin	  were	  drawn	  in	  all	  subjects.	  	  In	  our	  study,	  dysglycemia	  were	  evaluated	  from	  these	  results.	  	  Dysglycemia	  was	  defined	  as	  individuals	  who	  have	  a	  fasting	  serum	  glucose	  between	  100	  -­‐125	  mg/dL.	  The	  Insulin	  Resistance	  was	  calculated	  using	  the	  Homeostasis	  Model	  Assessment	  (HOMA-­‐IR)	  at	  the	  baseline	  and	  6	  month	  marks	  [24].	  The	  HOMA-­‐IR	  model	  uses	  the	  fasting	  plasma	  insulin	  and	  glucose	  concentrations	  to	  estimate	  insulin	  resistance.	  	  The	  equation	  used	  to	  calculate	  the	  HOMA-­‐IR	  was:	  	  
HOMA-­‐IR=	  (FPI	  x	  FPG)/22.5	  [24]	  In	  this	  equation	  FPI	  is	  fasting	  plasma	  insulin	  and	  FPG	  is	  fasting	  plasma	  glucose.	  	  	  
Lipids,	  Lipoproteins,	  and	  Inflammatory	  Markers	  In	  addition,	  fasting	  blood	  levels	  for	  cholesterol,	  high-­‐density	  lipoproteins	  (HDL)-­‐C,	  low-­‐density	  lipoproteins	  (LDL-­‐C),	  triglycerides,	  apo	  lipoprotein	  A	  (Apo	  A-­‐
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1),	  apo	  lipoprotein	  B	  (ApoB),	  c-­‐reactive	  protein	  (CRP),	  and	  oxidized	  LDL	  was	  measured	  using	  oxidized	  low-­‐density	  lipoprotein	  (Oxd	  LDL)	  in	  all	  subjects.	  	  	  Statistical	  analysis	  was	  performed	  to	  examine	  the	  differences	  at	  the	  baseline	  and	  6-­‐month	  mark.	  We	  used	  mean	  and	  standard	  deviation	  to	  report	  changes.	  	  We	  also	  examined	  racial	  differences	  in	  these	  results.	  	  
III.4	  Weight	  Loss	  Intervention	  and	  Education	  Program	  All	  subjects	  were	  placed	  on	  a	  diet	  induced	  weight	  loss	  program	  for	  6	  months.	  	  This	  dietary	  program	  consisted	  of	  meal	  replacements	  with	  Slim-­‐Fast	  3-­‐2-­‐1	  [20].	  	  This	  low	  calorie	  diet	  contained	  3	  snacks	  (100	  calories	  each),	  2	  meal	  replacement	  shakes,	  and	  1	  balanced	  meal.	  	  The	  additional	  meal	  consisted	  of	  50%	  carbohydrates,	  30%	  fat,	  and	  20%	  protein,	  and	  the	  Slim-­‐Fast	  had	  180-­‐190	  kcal	  each	  (9	  g	  total	  fat;	  4	  g	  total	  carbohydrate,	  20	  g	  protein,	  and	  2	  g	  fiber).	  These	  Slim-­‐Fast	  shakes	  were	  also	  supplemented	  with	  100%	  Vitamin	  E,	  100%	  Vitamin	  C,	  and	  35%	  Carotenoids.	  	  Subjects	  also	  attended	  the	  Comprehensive	  Weight	  Loss	  Management	  Program	  (CWP)	  at	  the	  Ohio	  State	  University.	  	  This	  was	  a	  6	  month	  lifestyle	  and	  education	  program	  where	  participants	  met	  weekly.	  	  Topics	  discussed	  were	  good	  nutrition,	  healthy	  weight	  loss	  tips,	  and	  physical	  activity[22].	  	  Subjects	  were	  given	  selections	  of	  healthy	  snacks,	  as	  well	  as	  consultation	  of	  how	  to	  put	  together	  healthy	  meals.	  	  Subjects	  were	  weighed	  in	  bi-­‐weekly,	  and	  consulted	  on	  their	  dietary	  changes.	  	  	  	  
IV.	  Results	  
IV.1	  Anthropometric	  Results	  
	   The	  subjects	  in	  our	  study	  were	  24	  White	  Americans	  (mean	  age	  43	  ±	  14	  years;	  mean	  BMI	  37	  ±	  5	  kg/m2;	  mean	  BP	  127/81	  mmHg)	  and	  25	  African	  Americans	  (mean	  age	  45	  ±	  9	  years,	  mean	  BMI	  38	  ±6	  kg/m2;	  mean	  BP	  127/81	  mmHg).	  	  	   The	  anthropometric	  data	  for	  the	  subjects	  can	  be	  found	  in	  Table	  1.	  	  While	  the	  White	  American	  subjects	  exhibited	  both	  significant	  weight	  loss	  	  (-­‐10.9754	  ±	  1.33	  kg;	  P<0.0001)	  and	  a	  decrease	  in	  BMI	  (-­‐5.1760	  ±	  1.17	  kg/m2;	  P<0.0001),	  African	  American	  subjects	  exhibited	  a	  significant	  decrease	  in	  weight	  loss	  (-­‐5.0400	  ±	  1.30	  kg;	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P=0.0003),	  but	  no	  significant	  decrease	  in	  BMI	  (-­‐1.8568	  ±	  1.15	  kg/m2;	  P=1.1123).	  	  The	  waist	  circumference	  of	  the	  White	  American	  subjects	  significantly	  decreased	  	  	  	  	  	  	  	  -­‐9.9742	  ±	  1.62	  cm	  (P<0.0001),	  and	  the	  waist	  circumference	  of	  the	  African	  American	  subjects	  had	  a	  decrease	  -­‐3.3232	  ±	  1.59	  cm	  (P=0.0419),	  which	  was	  not	  significant.	  	  White	  Americans	  had	  a	  significant	  decrease	  in	  systolic	  and	  diastolic	  blood	  pressure	  	  (-­‐10.5833	  ±	  2.04	  mmHg	  (P<0.0001)	  and	  -­‐6.4583	  ±	  1.46	  mmHg	  (P<0.0001)	  respectively).	  	  African	  Americans	  had	  an	  insignificant	  decrease	  in	  systolic	  and	  diastolic	  blood	  pressure	  (-­‐3.3200	  ±	  2.00	  mmHg	  (P=0.1030)	  and	  -­‐2.8400	  ±	  1.43	  mmHg	  (P=0.0537)	  respectively).	  	  We	  found	  racial	  differences	  in	  our	  groups	  in	  response	  to	  weight	  loss	  with	  regards	  to	  weight,	  waist	  circumference.	  	  These	  values	  only	  different	  at	  the	  6	  month	  mark,	  not	  at	  the	  baseline.	  	  White	  Americans	  lost	  5.94	  ±	  1.86	  kg	  (P=0.0025)	  and	  6.651	  ±2.27	  cm	  (P=0.0052)of	  waist	  circumference	  more	  than	  African	  American	  subjects.	  	  In	  addition,	  we	  found	  differences	  in	  systolic	  blood	  pressure	  and	  pulse.	  White	  Americans	  decreased	  their	  systolic	  blood	  pressure	  and	  average	  pulse	  7.26	  ±	  2.85	  mmHg	  (P=0.0142)	  and	  7.32	  ±	  2.71	  beats/min	  (P=0.0095)	  more	  than	  African	  American	  subjects.	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Table	  1A	  and	  1B:	  Anthropometric	  results	  at	  baseline	  and	  6	  months	  of	  a	  	  diet-­‐induced	  weight	  loss	  program.	  	  	  	  
BMI	  calculated	  from	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  equation;	  BMI,	  body	  mass	  index	  BP,	  Blood	  Pressure	  *	  Indicates	  significant	  changes	  over	  the	  6-­‐month	  period.	  Difference	  is	  significant	  if	  the	  P-­‐value	  is	  below	  0.0161	  
Weight	  (kg)	  Height	  (m)2	  
Table	  1A	  
Table	  1B	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IV.2	  Nutrient	  Results	  	  The	  nutrient	  changes	  in	  the	  subjects	  can	  be	  viewed	  in	  Table	  2.	  	  While	  both	  subjects	  did	  decrease	  their	  caloric	  intake,	  only	  White	  American	  subjects	  had	  a	  significant	  decrease	  of	  -­‐798.25	  ±231.77	  kcal	  	  (P=0.0012)	  over	  the	  6	  month	  period;	  African	  American	  subjects	  decreased	  their	  caloric	  intake	  -­‐412.40	  ±	  227.08	  kcal	  (P=0.0757).	  White	  Americans	  changed	  their	  carbohydrate	  intake	  by	  -­‐61.25	  ±	  28.68	  g	  (P=0.0380)	  and	  +6.50	  ±	  1.67%	  (P=0.0003)	  over	  the	  6-­‐month	  period.	  	  Their	  fat	  intake	  decreased	  -­‐51.25	  ±	  12.31	  g	  (P=0.0001)	  and	  -­‐9.08	  ±	  1.60%	  (P<0.0001).	  	  They	  decreased	  their	  saturated	  fats,	  monounsaturated	  fats,	  and	  polyunsaturated	  fats	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐19.09	  ±	  4.62	  g	  (P=0.0001),	  -­‐17.36	  ±	  4.70	  g	  (P=0.0006),	  and	  -­‐9.42	  ±2.37	  g	  (P=0.0002)	  respectively.	  	  Their	  omega-­‐3	  intake	  increased	  0.0417	  ±	  0.03	  g	  (P=0.2359).	  	  	  Their	  grams	  of	  protein	  decreased	  -­‐19.29	  ±	  9.05	  (P=0.0383),	  but	  their	  protein	  percentage	  increased	  2.92	  ±	  0.73%	  (P=0.0002).	  	  Their	  cholesterol	  intake	  decreased	  -­‐175.17	  ±37.54	  g	  (P<0.0001).	  	  	  Their	  intake	  of	  Vitamin	  E,	  C,	  and	  Carotenoids	  increased	  14.23	  ±	  3.47	  mg	  (P=0.0002),	  39.46	  ±	  20.96	  mg	  (P=0.0660),	  and	  236.56	  ±	  229.42	  μg	  (P=	  0.3078)	  respectively	  after	  6	  months.	  	  Only	  the	  vitamin	  E	  intake	  in	  our	  WA	  subjects	  had	  a	  significant	  change.	  	  	  In	  our	  African	  American	  subjects	  their	  carbohydrate	  intake	  changed	  -­‐5.40	  ±	  28.10	  g	  (P=0.8484)	  and	  +6.200	  ±	  1.63%	  (P=0.0004)	  over	  the	  6-­‐month	  period.	  	  Their	  fat	  intake	  decreased	  -­‐36.56	  ±	  12.06	  g	  (P<0.0001)	  and	  -­‐96.96±	  1.57%	  (P=0.0039).	  	  They	  decreased	  their	  saturated	  fats,	  monounsaturated	  fats,	  and	  polyunsaturated	  fats	  -­‐13.0440	  ±	  4.53	  g	  (P=0.0060),	  -­‐13.02	  ±	  4.60	  g	  (P=0.0069),	  and	  -­‐7.86	  ±2.32	  g	  (P=0.0014)	  respectively.	  	  Their	  omega-­‐3	  intake	  decreased	  0.04	  ±	  0.03	  g	  (P=0.2453).	  	  	  Their	  grams	  of	  protein	  decreased	  -­‐9.40	  ±	  8.87	  (P=0.2946),	  but	  their	  protein	  percentage	  increased	  1.28	  ±	  0.72%	  (P=0.0804).	  	  Their	  cholesterol	  intake	  decreased	  -­‐115.88	  ±36.78	  g	  (P=0.0804).	  	  	  Their	  vitamin	  intake	  of	  Vitamin	  E,	  C,	  and	  Carotenoids	  all	  increased	  significantly,	  seeing	  changes	  of	  14.04	  ±	  3.40	  mg	  (P=0.0001),	  82.04	  ±	  20.54	  mg	  (P=0.0002),	  and	  715.22	  ±	  224.79	  μg	  (P=	  0.0026)	  respectively.	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At	  both	  baseline	  and	  6	  months,	  the	  vitamin	  intake	  between	  the	  WA	  and	  AA	  subjects	  were	  not	  significantly	  different.	  The	  specific	  changes	  of	  vitamin	  intake	  before	  and	  after	  the	  weight	  loss	  program	  can	  be	  seen	  in	  Figures	  1	  and	  2.	  	  	  	  	  	   	  
Table	  2	  A	  and	  B:	  Nutrient	  Intake	  at	  baseline	  and	  6	  months	  of	  a	  diet	  induced	  weight	  loss	  program.	  	  
Kcal,	  kilocalories	  %	  Total	  Diet	  is	  the	  percent	  of	  each	  macronutrient	  represented	  in	  the	  total	  calorie	  intake.	  	  Carbohydrates	  and	  Protein	  both	  yield	  4	  kcal/g,	  Fat	  yields	  9	  kcal/g.	  	  	  *Indicates	  significant	  changes	  over	  a	  6	  month	  period.	  The	  mean	  difference	  is	  significant	  if	  the	  P-­‐value	  is	  less	  than	  0.0161	  
Table	  2A	  
Table	  2B	  
	   13	  
	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	   	  
Figures	  1	  and	  2:	  Vitamin	  Intake	  in	  Subjects	  at	  baseline	  and	  6	  months	  of	  a	  diet	  induced	  weight	  loss	  program	  compared	  to	  National	  Average	  and	  RDI.	  
	  




*	   *	  
*	  
Vitamin	  Intake	  in	  White	  Americans	  over	  a	  6-­‐Month	  Period	  on	  a	  Diet	  
Induced	  Weight	  Loss	  Program	  compared	  to	  National	  Average	  and	  RDI	  
Vitamin	  Intake	  in	  White	  Americans	  over	  a	  6-­‐Month	  Period	  on	  a	  Diet	  
Induced	  Weight	  Loss	  Program	  compared	  to	  National	  Average	  and	  RDI	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IV.3	  Metabolic	  Studies	  The	  serum	  glucose	  and	  hemoglobin	  A1C	  levels	  are	  shown	  in	  Table	  3	  A	  &	  B.	  	  Insulin	  resistance	  was	  measured	  through	  HOMA-­‐IR	  [25].	  	  White	  American	  subjects	  had	  a	  decrease	  in	  fasting	  blood	  glucose	  of	  -­‐2.29	  ±	  2.86	  mg/dL	  (P=0.4270),	  and	  a	  decrease	  in	  2-­‐hour	  blood	  glucose	  of	  -­‐13.92	  ±	  6.91	  mg/dL	  (P=0.0499)	  over	  the	  6	  month	  period.	  The	  hemoglobin	  A1C	  levels	  decreased	  by	  -­‐0.20	  ±0.07%	  (P=0.0064)	  over	  the	  6-­‐month	  period.	  	  	  The	  HOMA-­‐IR	  in	  the	  White	  American	  subjects	  decreased	  by	  -­‐0.72	  ±0.32	  (P=0.0297).	  The	  African	  American	  subjects	  had	  a	  decrease	  of	  -­‐4.08	  ±	  2.80	  mg/dL	  (P=0.152)	  in	  their	  fasting	  blood	  glucose,	  and	  a	  decrease	  of	  -­‐0.88	  ±	  6.78	  mg/dL	  (P=0.8972)	  in	  their	  2-­‐hour	  blood	  glucose	  over	  the	  6	  month	  period.	  	  Their	  hemoglobin	  A1C	  decreased	  by	  -­‐0.15	  ±	  0.07%	  (P=0.0318).	  	  Their	  HOMA-­‐IR	  decreased	  by	  -­‐0.74	  ±0.31	  (P=0.0221).	  	  The	  WA	  subjects	  had	  a	  decrease	  in	  fasting	  serum	  insulin	  of	  -­‐2.59	  ±	  21.99	  mg/dL	  (P=0.0392),	  and	  had	  a	  significant	  decrease	  in	  their	  2-­‐hr	  serum	  insulin	  of	  -­‐38.20	  ±	  11.34	  mg/dL	  (P=0.0015).	  	  The	  AA	  subjects	  saw	  a	  decrease	  in	  their	  fasting	  serum	  insulin	  of	  -­‐2.90	  ±	  1.22	  mg/dL	  (P=0.0217),	  and	  a	  decrease	  in	  their	  2-­‐hr	  serum	  insulin	  of	  -­‐5.98	  ±	  11.11	  mg/dL	  (P=0.5926).	  	  We	  found	  significant	  changes	  in	  A1C	  and	  2-­‐hr	  Insulin	  among	  WA	  subjects,	  but	  not	  AA	  subjects.	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	  
Table	  3	  A	  and	  B:	  Blood	  glucose	  and	  metabolic	  markers	  in	  subjects	  at	  baseline	  and	  6	  months	  of	  a	  diet-­‐induced	  weight	  loss	  program.	  	  	  
2	  hour	  blood	  glucose	  tolerance	  test	  was	  completed	  using	  75	  mg	  of	  glucose.	  	  HOMA-­‐IR,	  Homeostatic	  model	  assessment	  	  A1C,	  Hemoglobin	  A1C	  *indicates	  significant	  changes	  over	  the	  6	  month	  period.	  The	  mean	  difference	  is	  significant	  if	  the	  P-­‐value	  is	  less	  than	  0.0161	  	  
Table	  3	  A	  
Table	  3	  B	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IV.4	  Lipids	  and	  Lipoproteins	  The	  serum	  lipids	  and	  lipoprotein	  amounts	  can	  be	  seen	  in	  Table	  4	  A	  &	  B.	  	  The	  White	  American	  subjects	  decreased	  their	  total	  cholesterol	  by	  -­‐11.00	  ±	  4.64	  mg/dL	  (P=0.0221)	  over	  the	  6	  month	  period.	  	  Their	  HDL	  –C	  increased	  +2.70	  ±1.50	  mg/dL	  (P=0.0783),	  and	  their	  LDL-­‐C	  decreased	  -­‐8.78	  ±	  4.08	  mg/dL	  (P=0.0364).	  	  Their	  triglycerides	  significantly	  decreased	  by	  -­‐25.17	  ±	  7.90	  mg/dL	  (P=0.0026).	  	  Apo	  lipoprotein	  A-­‐1	  and	  Apo	  lipoprotein	  B	  increased	  by	  2.08	  ±3.42	  U/dL	  (P=0.5453)	  and	  decreased	  by	  -­‐8.30	  ±2.61	  U/dL	  (P=0.0026)	  respectively.	  	  The	  African	  American	  subjects	  had	  a	  decrease	  of	  -­‐8.00	  ±4.45	  mg/dL	  (P=0.0221)	  in	  their	  total	  cholesterol	  over	  the	  6-­‐month	  period.	  	  Their	  HDL-­‐C	  and	  LDL-­‐C	  decreased	  by	  -­‐0.16	  ±1.44	  mg/dL	  (P=0.9117)	  and	  -­‐6.76	  ±	  3.91	  mg/dL	  (P=0.0905)	  respectively,	  but	  was	  not	  significant.	  	  Their	  triglycerides	  decreased	  -­‐9.88	  ±7.57	  mg/dL	  (P=0.1986).	  	  The	  Apo	  lipoprotein	  A1	  and	  Apo	  lipoprotein	  B	  decreased	  -­‐5.24	  ±	  3.29	  U/dL	  (P=0.1175)	  and	  -­‐0.67	  ±	  2.55	  U/dL	  (P=0.7952).	  These	  can	  also	  be	  seen	  in	  Figures	  3	  and	  4.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Table	  4	  A	  and	  B:	  Lipid	  and	  Lipoprotein	  levels	  in	  subjects	  at	  baseline	  and	  6	  months	  of	  a	  diet-­‐induced	  weight	  loss	  program.	  	  	  
HDL-­‐C,	  High	  Density	  Lipoprotein	  Cholesterol	  LDL-­‐C,	  Low	  Density	  Lipoprotein	  Cholesterol	  ApoA1,	  Apoprotein	  A1	  ApoB,	  Apoprotein	  B	  *	  Indicates	  significant	  difference	  over	  the	  6	  month	  period	  The	  mean	  difference	  is	  significant	  if	  the	  P-­‐value	  is	  less	  than	  0.0161	  	  
Table	  4	  A	  
Table	  4	  B	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Figures	  3	  and	  4:	  Cholesterol,	  Lipid,	  and	  Lipoprotein	  levels	  in	  subjects	  at	  baseline	  and	  6	  months	  of	  a	  diet-­‐induced	  weight	  loss	  program.	  	  	  	  
*Indicates	  significant	  difference	  over	  the	  6	  month	  period	  The	  mean	  difference	  is	  significant	  if	  the	  P-­‐value	  is	  less	  than	  0.0161	  	  
Figure	  3	  
Figure	  4	  
	  *	   *	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IV.5	  Inflammation	  and	  Oxidized	  LDL	  	   The	  changes	  of	  the	  inflammatory	  markers	  amounts	  can	  be	  viewed	  in	  Table	  5.	  There	  were	  no	  significant	  changes	  in	  c-­‐reactive	  protein	  or	  oxidized	  LDL	  levels	  over	  the	  6	  month	  period.	  	  The	  c-­‐reactive	  protein	  (CRP)	  decreased	  -­‐2.14	  ±1.01	  mg/dL	  (P=0.0400)	  in	  the	  White	  American	  subjects,	  and	  the	  oxidized	  low-­‐density	  lipoprotein	  increased	  0.9043	  ±	  3.98	  U/L	  (P=0.8213)	  over	  the	  6-­‐month	  period.	  	  The	  African	  American	  subjects	  had	  a	  decrease	  of	  -­‐1.25	  ±	  0.95	  mg/dL	  (P=0.1932)	  in	  their	  c-­‐reactive	  protein,	  and	  an	  increase	  of	  4.94	  ±	  3.52	  U/L	  (P=0.1679)	  in	  their	  oxidized	  low-­‐density	  lipoprotein	  over	  the	  6	  month	  period.	  	  None	  of	  these	  changes	  were	  statistically	  significant	  among	  our	  AA	  and	  WA	  subjects.	  	  	  	  	  	  	  	  	   	  
Table	  5:	  Inflammatory	  marker	  levels	  in	  subjects	  at	  baseline	  and	  6	  months	  of	  a	  diet-­‐induced	  weight	  loss	  program.	  	  
CRP,	  c-­‐reactive	  protein;	  Oxidized	  LDL,	  oxidized	  low-­‐density	  lipoprotein	  *Indicates	  significant	  difference	  over	  the	  6	  month	  period.	  The	  mean	  difference	  is	  significant	  if	  the	  P-­‐value	  is	  less	  than	  0.0161	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V.	  Discussion	  
V.1	  Antropometric	  Results	   	  This	  study	  demonstrated	  that	  the	  SlimFast	  3-­‐2-­‐1	  plan	  was	  successful	  in	  helping	  overweight	  and	  obese,	  dysglycemic	  subjects	  lose	  weight.	  	  The	  weight	  loss	  study	  was	  also	  successful	  in	  generally	  increasing	  the	  dietary	  intake	  of	  Vitamin	  E,	  C,	  and	  Carotenoid.	  	  A	  1997	  study	  [44]	  showed	  that	  over	  extended	  periods	  of	  weight	  loss,	  limiting	  certain	  foods,	  counting	  calories,	  and	  limiting	  quantities	  of	  food	  were	  successful	  at	  losing	  significant	  amounts	  of	  weight.	  	  Our	  study	  focused	  on	  replacing	  meals	  with	  meal	  replacement	  shakes	  and	  using	  professional	  help	  to	  make	  healthier	  choices,	  instead	  of	  the	  weight	  loss	  method	  of	  limiting	  certain	  foods.	  	  The	  study	  mentioned	  above	  occurred	  for	  a	  year,	  where	  as	  our	  study	  only	  occurred	  over	  a	  6	  month	  period.	  The	  lack	  of	  significant	  change	  in	  the	  BMI	  of	  African	  American	  subjects,	  the	  6-­‐month	  period	  did	  not	  yield	  enough	  weight	  loss	  to	  significantly	  lower	  the	  BMI	  of	  the	  African	  American	  subjects.	  	  We	  speculate	  that	  some	  of	  these	  weight	  loss	  changes	  could	  be	  attributed	  to	  the	  100	  calorie	  snacks	  and	  the	  meal	  that	  the	  individual	  subjects	  chose.	  	  	  	   The	  weight	  loss	  program	  also	  did	  not	  significantly	  lower	  the	  waist	  circumference	  of	  the	  African	  American	  subjects	  over	  a	  6-­‐month	  period.	  	  The	  Look	  Ahead	  study	  [28],	  a	  weight	  loss	  intervention	  study	  incorporating	  decreased	  caloric	  intake	  and	  increased	  physical	  activity	  in	  subjects	  with	  type	  2	  diabetes,	  saw	  decreased	  waist	  circumference	  with	  decreased	  weight	  loss.	  	  The	  lack	  of	  significant	  waist	  circumference	  changes	  could	  indicate	  that	  more	  time	  is	  need	  to	  significantly	  decrease	  the	  circumference	  since	  the	  Look	  Ahead	  study	  took	  place	  over	  a	  year,	  rather	  than	  just	  6	  months.	  The	  Look	  Ahead	  study	  [29]	  also	  indicated	  that	  physical	  activity,	  not	  just	  decreased	  caloric	  intake	  alone,	  contributes	  greatly	  to	  decrease	  in	  BMI	  and	  waist	  circumference.	  	  The	  Diabetes	  Prevention	  Program	  [42,43]	  also	  included	  dietary,	  behavioral,	  and	  physical	  activity	  modifications	  in	  overweight	  and	  obese	  subjects.	  	  This	  study	  saw	  a	  decrease	  of	  weight	  in	  their	  subjects.	  	  This	  was	  also	  observed	  in	  the	  NHANES	  1999-­‐2002	  survey	  where	  they	  observed	  an	  inverse	  relationship	  between	  physical	  fitness	  and	  BMI	  [30].	  	  The	  above	  studies	  have	  similar	  lifestyle	  interventions	  that	  our	  subjects	  received	  counseling	  on	  during	  our	  study.	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These	  studies	  indicate	  that	  the	  diet-­‐induced	  weight	  loss	  program	  alone	  might	  not	  be	  as	  successful	  as	  a	  program	  with	  a	  combined	  diet	  and	  physical	  activity	  plan.	  	  Our	  weight	  loss	  program	  had	  other	  important	  benefits.	  	  For	  example,	  we	  found	  that	  blood	  pressure	  significantly	  decreased	  in	  WA,	  but	  not	  in	  AA.	  	  Subjects	  were	  allowed	  to	  be	  on	  blood	  pressure	  medication	  during	  the	  study,	  and	  had	  a	  blood	  pressure	  below	  the	  high-­‐risk	  blood	  pressure	  of	  130/85	  mmHg	  in	  patients	  with	  metabolic	  syndrome.	  [27]	  The	  significant	  decrease	  in	  blood	  pressure	  in	  the	  White	  American	  subjects	  indicates	  that	  the	  diet-­‐induced	  weight	  loss	  program	  was	  successful	  of	  lowering	  blood	  pressure	  regardless	  of	  the	  medication.	  	  Subjects	  in	  the	  Diabetes	  Prevention	  Program	  and	  the	  Look	  Ahead	  Trial	  both	  reported	  decreases	  in	  blood	  pressure.	  [28,29,	  42]	  	  This	  confirms	  the	  need	  for	  combined	  dietary	  and	  physical	  activity	  programs.	  	  	  
V.2	  Metabolic	  Studies	  	   In	  our	  study,	  dysglycemia	  was	  defined	  as	  having	  a	  	  fasting	  glucose	  and	  2-­‐hr	  blood	  glucose	  of	  100-­‐125	  mg/dL	  and	  140-­‐199	  mg/dL	  respectively,	  and	  A1C	  values	  between	  5.7	  and	  7.0.	  	  Our	  subjects	  demonstrated	  significant	  decrease	  in	  fasting	  blood	  glucose	  from	  baseline	  to	  6	  months	  (WA	  subjects	  decreased	  from	  102.17	  mg/dL	  to	  99.58	  mg/dL	  (P=	  0.427);	  AA	  subjects	  decreased	  from	  101.12	  mg/dL	  to	  97.04	  mg/dL	  (P=0.1520)).	  	  This	  suggests	  that	  moderate	  weight	  loss	  is	  beneficial	  in	  decreasing	  dysglycemia.	  	  The	  A1C	  levels	  of	  the	  White	  American	  Subjects	  did	  significantly	  decrease	  by	  -­‐0.2%	  (P=0.0064),	  indicating	  that	  the	  amount	  of	  glycated	  hemoglobin	  decreased	  over	  the	  6-­‐month	  period.	  The	  significant	  change	  was	  not	  observed	  in	  the	  African	  American	  subjects.	  	  The	  Look	  Ahead	  trial	  indicated	  significant	  changes	  in	  hemoglobin	  A1C	  amounts	  in	  subjects	  that	  combine	  dietary	  changes,	  physical	  activity,	  and	  behavioral	  modifications	  [28].	  	  The	  Diabetes	  Prevention	  Program	  [42,43],	  which	  used	  a	  similar	  program	  including	  diet	  and	  behavior	  modifications	  in	  overweight	  and	  obese	  subjects,	  saw	  that	  the	  subjects	  reduced	  their	  risk	  of	  developing	  diabetes	  by	  58%.	  We	  did	  not	  observe	  a	  significant	  change	  in	  the	  HOMA-­‐IR	  value,	  indicating	  that	  the	  subjects	  insulin	  resistance	  did	  not	  significantly	  change	  in	  response	  to	  weight	  loss.	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V.3	  Caloric	  and	  Macronutrient	  Intake	  The	  Slimfast	  3-­‐2-­‐1	  program	  helped	  subjects	  successfully	  lower	  their	  caloric	  intake,	  while	  also	  increasing	  their	  vitamin	  intake.	  	  The	  program	  was	  also	  successful	  in	  lowering	  the	  caloric	  intake	  of	  the	  subjects	  below	  the	  2000	  kcal	  that	  is	  recommended	  for	  the	  average	  American	  diet.	  	  In	  general,	  the	  WA	  caloric	  intake	  decreased	  from	  2700	  calories	  to	  1960	  calories	  over	  the	  6	  month	  period;	  and	  the	  AA	  caloric	  intake	  generally	  decreased	  from	  2300	  calories	  to	  1900	  calories	  over	  the	  6	  month	  period.	  	  While	  only	  the	  White	  American	  subjects	  differences	  were	  significant	  (-­‐789.25	  ±	  231.77;	  P=0.0012),	  both	  groups	  were	  successful	  in	  lowering	  their	  caloric	  intake	  below	  the	  2,000	  calorie	  mark.	  	  The	  lack	  of	  significant	  changes	  in	  the	  African	  American	  subjects	  could	  be	  because	  they	  had	  a	  much	  lower	  caloric	  intake	  at	  the	  beginning	  of	  the	  study,	  therefore	  they	  did	  not	  have	  to	  reduce	  their	  caloric	  intake	  as	  much.	  	  The	  subjects’	  carbohydrate,	  fat,	  and	  protein	  ratios	  were	  also	  modified	  to	  be	  in	  the	  range	  of	  the	  recommended	  diet	  of	  45-­‐65%	  carbohydrates,	  20-­‐35%	  fats,	  and	  10-­‐35%	  protein.	  	  From	  this,	  we	  suspect	  that	  the	  subjects	  were	  successful	  in	  achieving	  a	  healthier	  proportion	  of	  macronutrients	  in	  their	  diet.	  	  The	  Center	  for	  Disease	  Control	  recommends	  having	  no	  more	  than	  10%	  of	  our	  daily	  calories	  be	  from	  saturated	  fats	  in	  order	  to	  prevent	  cardiovascular	  disease	  [31].	  	  Diets	  high	  in	  saturated	  fats	  and	  low	  in	  polyunsaturated	  fats	  increase	  blood	  cholesterol	  levels,	  thus	  contributing	  to	  cardiovascular	  disease	  risk.	  	  The	  White	  American	  subjects	  were	  successful	  in	  reducing	  their	  average	  percentage	  of	  saturated	  fat	  intake	  from	  13.44%	  to	  10.15%,	  and	  the	  African	  American	  subjects	  successfully	  reduced	  their	  average	  percentage	  of	  saturated	  fat	  intake	  from	  13.86%	  to	  10.72%.	  	  Hu	  et	  al.	  completed	  a	  study	  in	  1999	  that	  indicated	  a	  diet	  that	  replaces	  saturated	  fat	  intake	  with	  polyunsaturated	  fat	  intake	  has	  been	  successful	  in	  lowering	  cardiovascular	  disease	  risk	  [32].	  	  However,	  a	  review	  that	  looked	  at	  recent	  studies	  of	  how	  saturated	  fat	  intake	  related	  to	  cardiovascular	  disease	  indicated	  that	  there	  was	  a	  weak	  association	  with	  saturated	  fat	  intake	  and	  cardiovascular	  disease	  risk.	  	  The	  author	  instead	  suggested	  that	  the	  types	  of	  nutrients	  that	  replace	  the	  saturated	  fat	  may	  have	  more	  to	  do	  with	  the	  decreased	  risk	  [33].	  	  Our	  study	  did	  not	  account	  for	  replacing	  saturated	  fat	  with	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polyunsaturated	  fats	  or	  other	  nutrients,	  so	  we	  are	  unable	  to	  make	  these	  same	  conclusions.	  	  	  
V.4	  Vitamin	  Intake	  	   The	  National	  Institute	  of	  Health	  fact	  sheet	  states	  that	  the	  RDI	  for	  Vitamin	  E	  is	  15	  mg/day,	  Vitamin	  C	  is	  75-­‐90	  mg/day,	  and	  Carotenoids	  are	  700-­‐900	  μg/day	  [26].	  	  The	  fact	  sheets	  also	  indicate	  that	  the	  national	  average	  of	  intake	  for	  Vitamin	  E	  is	  between	  19.3-­‐24.9	  mg/day,	  for	  Vitamin	  C	  is	  83.6	  mg/day	  for	  women	  and	  105.2	  mg/day	  for	  men,	  and	  for	  Carotenoids	  are	  580	  μg/day	  for	  women	  and	  649	  μg/day	  for	  men	  [26].	  	  In	  our	  study,	  we	  found	  that	  the	  vitamin	  intake	  of	  E,	  C,	  and	  Carotenoids	  were	  above	  the	  RDI	  and	  national	  average	  at	  the	  baseline.	  A	  positive	  aspect	  of	  our	  weight	  loss	  intervention	  was	  that	  the	  caloric	  intake	  decreased,	  the	  intake	  of	  vitamins	  increased	  as	  shown	  on	  Figures	  1	  and	  2.	  	  The	  SlimFast	  shakes	  accounted	  for	  some	  of	  these	  vitamins	  intakes,	  with	  a	  single	  shake	  having	  around	  15	  mg	  of	  Vitamin	  E	  (100%),	  75-­‐90	  mg	  Vitamin	  C	  (100%),	  and	  245-­‐315	  μg	  of	  Carotenoids	  (35%)	  [21].	  	  We	  can	  assume	  from	  the	  numbers	  reported	  in	  the	  food	  frequency	  questionnaires	  that	  the	  consumption	  of	  these	  vitamins	  were	  increased.	  	  We	  can	  also	  assume	  that	  the	  other	  factor	  for	  the	  increase	  of	  vitamin	  intake	  comes	  from	  the	  types	  of	  snacks	  and	  full	  meal	  the	  subject	  chose	  to	  eat,	  as	  there	  are	  certain	  foods	  that	  are	  high	  in	  the	  vitamins	  with	  antioxidant	  functions.	  	  Foods	  high	  in	  Vitamin	  E	  are	  nuts,	  seeds,	  vegetable	  oils,	  green	  leafy	  vegetables,	  and	  fortified	  cereals;	  foods	  rich	  in	  Vitamin	  C	  are	  citrus	  fruits,	  tomatoes	  and	  tomato	  juices,	  potatoes,	  peppers,	  and	  strawberries;	  foods	  rich	  in	  carotenoids	  are	  carrots,	  sweet	  potatoes,	  dark	  leafy	  greens,	  and	  tomatoes.	  	  A	  2011	  study	  showed	  that	  higher	  fruit	  content	  in	  a	  low	  calorie	  diet	  improved	  antioxidant	  status	  during	  weight	  loss,	  and	  that	  tomato	  and	  spinach	  specifically	  (high	  in	  Vitamin	  E	  and	  Carotenoids)	  prevented	  oxidative	  stress	  [38].	  	  The	  subjects	  in	  our	  study	  attended	  the	  6	  month	  “Living	  Well	  Program”	  at	  the	  Comprehensive	  Weight	  Management	  Program.	  	  This	  program	  reviewed	  ways	  to	  maintain	  a	  healthier	  lifestyle,	  and	  encouraged	  subjects	  to	  find	  way	  to	  increase	  their	  fruit	  and	  vegetable	  intake	  as	  a	  way	  to	  get	  these	  antioxidant	  vitamins.	  	  Therefore,	  it	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adding	  additional	  benefits	  for	  the	  subjects	  involved	  in	  the	  Weight	  Management	  Program.	  	  	  
V.5	  Lipids	  and	  Lipoproteins	  	   Elevated	  lipids	  and	  lipoproteins	  are	  associated	  with	  increased	  cardiovascular	  disease	  risk.	  	  In	  our	  study,	  we	  found	  HDL	  to	  be	  below	  the	  recommended	  value	  of	  50	  mg/dL	  before	  and	  after	  our	  study.	  	  Similiarly,	  LDL-­‐C	  followed	  the	  same	  trend	  with	  the	  LDL	  levels	  over	  the	  value	  of	  100	  mg/dL	  before	  and	  after	  our	  study.	  An	  increased	  HDL-­‐C	  amount	  is	  important	  because	  HDL-­‐C	  works	  to	  collect	  LDL-­‐C	  and	  recycle	  it	  back	  to	  the	  liver,	  therefore	  preventing	  its	  oxidation.	  	  HDL-­‐C	  also	  works	  to	  keep	  the	  endothelial	  lining	  of	  the	  artery	  healthy.	  	  A	  high	  amount	  of	  LDL-­‐C	  would	  mean	  that	  more	  would	  be	  available	  to	  be	  oxidized,	  and	  therefore	  more	  plaque	  would	  be	  formed	  on	  the	  arterial	  wall.	  	  A	  study	  performed	  in	  1994	  demonstrated	  that	  although	  Vitamin	  C	  is	  hypothesized	  to	  increase	  plasma	  HDL-­‐C	  concentration,	  supplementation	  has	  not	  been	  shown	  to	  have	  a	  significant	  increase	  in	  the	  plasma	  levels	  [34].	  	  This	  did	  not	  correlate	  with	  the	  results	  seen	  in	  our	  study,	  since	  an	  increase	  in	  Vitamin	  C	  intake	  did	  not	  yield	  a	  significant	  increase	  in	  plasma	  HDL-­‐C	  concentrations.	  	  Other	  studies	  have	  also	  indicated	  no	  significant	  association	  between	  fruit	  and	  vegetable	  intake	  that	  contain	  these	  antioxidant	  vitamins	  and	  HDL-­‐C	  concentration	  [6].	  	  While	  the	  vitamin	  intake	  in	  our	  study	  did	  not	  correlate	  with	  changes	  in	  plasma	  lipid	  concentration,	  a	  study	  performed	  in	  elderly	  cardiovascular	  patients	  indicated	  that	  increased	  antioxidant	  supplementation	  (specifically	  Vitamin	  E)	  resulted	  in	  decreased	  lipid	  oxidation	  [38].	  	  However,	  while	  they	  received	  positive	  results,	  other	  studies	  have	  not	  shown	  this	  same	  result	  with	  Vitamin	  E	  supplementation	  [39].	  	  The	  authors	  noted	  that	  that	  the	  decreased	  lipid	  oxidation	  could	  have	  come	  from	  an	  increase	  of	  whole	  fruits	  and	  vegetables	  intake	  in	  patients	  who	  were	  already	  suffering	  from	  cardiovascular	  disease.	  	  Our	  study	  had	  vitamin	  supplementation	  in	  the	  Slimfast	  meal	  replacement	  shakes	  and	  vitamins	  from	  whole	  foods	  in	  the	  snacks	  and	  balanced	  meals,	  but	  we	  did	  not	  directly	  measure	  what	  	  caused	  an	  increase	  of	  vitamins	  in	  our	  subjects.	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Most	  large	  epidemiological	  studies	  show	  that	  AA	  have	  an	  increase	  in	  HDL	  when	  compared	  to	  WA,	  however	  while	  our	  study	  showed	  this	  increase	  in	  HDL	  levels	  in	  AA	  subjects,	  the	  increase	  with	  not	  significant	  either	  the	  baseline	  or	  6	  month	  period	  [19,41].	  	  Triglyceride	  levels	  have	  also	  showed	  to	  be	  lower	  in	  AA	  when	  compared	  to	  WA	  [19,41].	  	  Our	  study	  only	  showed	  AA	  to	  have	  significantly	  lower	  triglycerides	  at	  the	  baseline,	  but	  not	  at	  the	  6	  month	  mark.	  	  The	  dietary	  induced	  weight	  loss	  program	  was	  successful	  in	  decreasing	  the	  cholesterol	  levels	  in	  WA	  subjects,	  bring	  these	  levels	  to	  that	  of	  the	  AA	  subjects.	  	  The	  AA	  subjects	  in	  our	  group	  did	  not	  have	  a	  significant	  decrease	  in	  triglycerides,	  what	  may	  be	  related	  to	  their	  already	  lower	  numbers.	  	  The	  triglyceride	  levels	  are	  related	  to	  the	  amount	  of	  calories	  and	  fat	  in	  the	  diet	  because	  they	  store	  the	  unused	  calories	  that	  are	  not	  burned.	  	  Therefore,	  since	  the	  WA	  saw	  a	  significant	  decrease	  in	  calories,	  they	  also	  saw	  this	  significant	  decrease	  in	  triglycerides,	  while	  AA	  subjects	  did	  not	  see	  either.	  	  A	  larger	  population	  size	  could	  have	  increased	  the	  significance	  in	  the	  changes	  we	  saw	  between	  the	  AA	  and	  WA	  subjects.	  	  	  	  
V.6	  Inflammatory	  Markers	  	  Inflammation	  is	  considered	  a	  risk	  factor	  for	  cardiovascular	  disease,	  which	  can	  be	  caused	  by	  increased	  oxidation	  in	  the	  body.	  The	  inflammatory	  markers,	  such	  as	  c-­‐reactive	  protein	  (CRP)	  and	  oxidized	  LDL	  also	  exhibited	  no	  change	  over	  the	  6-­‐month	  period.	  	  C-­‐reactive	  protein	  is	  found	  in	  the	  blood	  in	  response	  to	  an	  increase	  of	  inflammation.	  The	  CRP	  binds	  to	  macrophages	  that	  attend	  to	  damaged	  cells,	  and	  are	  present	  in	  states	  of	  increased	  inflammation.	  CRP	  levels	  associated	  with	  an	  elevated	  risk	  of	  inflammation	  in	  the	  body	  and	  therefore	  cardiovascular	  disease	  are	  greater	  than	  3.0	  mg/dL.	  Based	  on	  the	  CRP	  levels	  at	  the	  end	  of	  the	  study,	  subjects	  had	  levels	  that	  were	  close	  to	  the	  normal	  levels.	  	  A	  2006	  study	  demonstrated	  the	  opposite	  results.	  	  The	  authors	  found	  an	  inverse	  relationship	  between	  vegetable	  intakes	  and	  CRP	  levels.	  	  A	  major	  difference	  between	  this	  study	  and	  ours	  was	  that	  not	  all	  the	  patients	  in	  their	  study	  were	  overweight	  or	  obese,	  and	  only	  some	  of	  them	  were	  characterized	  as	  having	  metabolic	  syndrome.	  	  In	  our	  study,	  all	  of	  the	  subjects	  were	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dysglycemic	  and	  overweight/obese,	  therefore	  haing	  2	  cardiovascular	  disease	  risk	  factors.	  	  These	  differences	  may	  contribute	  to	  findings	  between	  the	  study.	  	  The	  study	  comments	  that	  the	  correlation	  of	  CRP	  and	  vitamin	  intake	  could	  have	  only	  been	  present	  in	  the	  healthy	  subjects.	  	  They	  concluded	  that	  this	  might	  be	  related	  because	  of	  the	  assumption	  that	  they	  lead	  generally	  healthier	  lifestyles	  [6].	  	  An	  additional	  study	  that	  placed	  subjects	  on	  a	  restricted	  calorie	  diet	  for	  two	  years	  (1300	  kcal/day	  for	  the	  first	  year;	  1500kcal/day	  for	  the	  second	  year)	  saw	  reductions	  of	  CRP	  in	  subjects	  after	  losing	  15	  kg	  of	  weight	  and	  5.2	  kg/m2	  in	  their	  BMI.	  	  This	  study	  showed	  the	  effectiveness	  of	  reducing	  CRP	  levels	  during	  a	  long	  term	  weight	  loss	  program	  [37],	  in	  contrast	  to	  our	  6	  month	  study.	  	  Oxidation	  of	  LDL	  is	  closely	  associated	  with	  increased	  cardiovascular	  disease	  risk.	  	  Diets	  high	  in	  vitamin	  intake	  are	  typically	  associated	  with	  decreased	  LDL	  oxidation.	  	  Our	  study	  found	  that	  subjects	  did	  not	  change	  their	  oxidized	  LDL	  after	  the	  6-­‐month	  period.	  	  Studies	  that	  have	  found	  decreased	  levels	  of	  oxidized	  LDL	  have	  noted	  that	  oxidized	  LDL	  levels	  decrease	  because	  of	  very	  low	  caloric	  intake	  (580	  kcal/day	  [34])	  or	  significant	  weight	  loss	  of	  13	  kg	  or	  more	  [36].	  	  Our	  subjects	  were	  over	  the	  580	  kcal/day	  mark	  and	  lost	  less	  than	  13	  kg	  of	  weight	  over	  the	  6	  month	  period.	  Thus,	  it	  could	  be	  that	  if	  our	  study	  was	  extended	  longer,	  we	  would	  have	  demonstrated	  decreased	  oxidized	  LDL,	  as	  seen	  in	  the	  above	  study.	  A	  2011	  study	  that	  focused	  on	  the	  specific	  increase	  of	  antioxidant	  containing	  fruit	  and	  vegetable	  intake	  in	  healthy	  adults	  saw	  an	  inverse	  relationship	  between	  fruit	  and	  vegetable	  intake	  and	  oxidized	  LDL	  levels,	  especially	  in	  the	  diets	  that	  included	  only	  fruit	  juices	  [40].	  The	  dysglycemic	  state	  of	  the	  subjects	  in	  our	  study	  could	  have	  prevented	  this	  relationship	  to	  occur.	  	  The	  lack	  of	  significant	  change	  in	  these	  inflammatory	  markers	  indicate	  that	  the	  high	  antioxidant	  vitamin	  intake	  might	  not	  correlate	  to	  lower	  amounts	  of	  oxidized	  LDL	  in	  the	  blood	  stream.	  	  However,	  the	  lack	  of	  significant	  change	  could	  also	  be	  attributed	  to	  bioavailability	  of	  the	  antioxidants	  in	  the	  vitamins,	  or	  the	  way	  the	  vitamins	  are	  obtained	  (whole	  foods	  versus	  supplementation)	  [40].	  This	  lack	  of	  significant	  change	  was	  also	  seen	  in	  studies	  regarding	  vitamin	  supplementation	  [7,14,18].	  	  While	  there	  are	  varying	  results,	  there	  is	  no	  direct	  claim	  to	  one	  form	  of	  vitamin	  intake	  being	  better	  than	  the	  other.	  	  Even	  though	  we	  had	  a	  combination	  of	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vitamin	  intake,	  we	  did	  not	  see	  a	  decrease	  in	  the	  inflammatory	  markers.	  	  Therefore,	  additional	  studies	  are	  warranted	  to	  examine	  the	  benefits	  of	  vitamin	  supplements	  or	  vitamins	  from	  whole	  foods	  and	  weight	  loss	  as	  well	  as	  different	  sources	  of	  these	  vitamins.	  	  	  
V.7	  Limitations	  	   Our	  diet	  induced	  weight	  loss	  program	  resulted	  in	  reduction	  of	  weight,	  caloric	  intake,	  and	  blood	  pressure.	  	  We	  also	  saw	  an	  increase	  in	  overall	  intake	  of	  Vitamins	  E,	  C,	  and	  Carotenoids	  among	  our	  subjects.	  	  While	  we	  saw	  these	  positive	  changes,	  we	  did	  not	  see	  a	  change	  in	  lipid,	  lipoprotein,	  or	  inflammatory	  marker	  levels	  measured	  in	  our	  study.	  	  We	  also	  did	  not	  see	  metabolic	  changes	  through	  glucose	  and	  hemoglobin	  A1C	  levels.	  	  However,	  there	  are	  several	  limitations	  in	  our	  study	  that	  warrant	  discussion.	  	  We	  used	  a	  food	  frequency	  questionnaire	  to	  obtain	  the	  levels	  of	  caloric,	  macronutrient,	  and	  vitamin	  intake.	  	  Since	  the	  food	  frequency	  questionnaire	  compiles	  the	  general	  food	  intake	  over	  the	  past	  3-­‐months,	  it	  relies	  on	  subjects’	  recall	  of	  various	  aspects	  of	  their	  diet.	  This	  limited	  us	  because	  of	  the	  potential	  challenges	  of	  remembering	  food	  intake	  over	  the	  past	  3	  months,	  which	  may	  not	  be	  as	  accurate	  as	  a	  3-­‐7	  day	  food	  record	  or	  a	  24-­‐hour	  recall.	  	  Additional	  studies	  have	  also	  noted	  the	  potential	  inaccuracy	  with	  food	  frequency	  questionnaires	  because	  of	  their	  dependency	  on	  individual	  reporting	  [12].	  	  	  The	  food	  frequency	  questionnaire	  alone	  does	  not	  provide	  the	  serum	  levels	  of	  the	  vitamins,	  and	  does	  not	  account	  for	  if	  the	  vitamin	  is	  in	  its	  most	  bioavailable	  form.	  	  In	  our	  study,	  we	  reported	  only	  the	  dietary	  intake	  of	  vitamins,	  therefore	  we	  could	  not	  accurately	  correlate	  increases	  in	  vitamin	  intake	  with	  serum	  levels	  of	  the	  vitamins.	  By	  using	  the	  serum	  level	  in	  conjunction	  with24	  hour	  recall	  and	  asking	  specific	  questions	  related	  to	  fruit	  and	  vegetable	  intake	  it	  could	  be	  possible	  that	  we	  may	  observe	  significant	  increases	  in	  both	  dietary	  and	  serum	  levels	  of	  Vitamin	  E,	  C,	  and	  Caroteniods.	  Thus	  allowing	  us	  to	  look	  more	  accurately	  at	  the	  relationship	  between	  antioxidant	  vitamins	  and	  risk	  for	  cardiovascular	  disease.	  	  	  We	  observed	  a	  significant	  increase	  of	  reported	  dietary	  intake	  of	  Vitamin	  E,	  C,	  and	  Carotenoids	  from	  the	  food	  frequency	  questionnaires.	  	  These	  results	  can	  be	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confounded	  because	  of	  the	  high	  caloric	  intake	  of	  the	  subjects	  at	  the	  beginning	  of	  the	  study,	  therefore	  yielding	  an	  increased	  intake	  of	  the	  vitamins	  in	  general.	  	  We	  chose	  SlimFast	  3-­‐2-­‐1	  plan	  because	  it	  was	  easy	  for	  participants	  to	  follow,	  and	  we	  hoped	  it	  would	  encourage	  subjects	  to	  continue	  to	  lose	  weight	  once	  the	  study	  ended.	  	  A	  better	  dietary	  intervention	  could	  be	  to	  have	  one-­‐on-­‐one	  consultations	  with	  a	  dietician	  to	  develop	  a	  more	  individualized	  meal	  plan	  that	  contained	  foods	  the	  subjects	  enjoyed,	  therefore	  potentially	  increasing	  their	  weight	  loss	  and	  healthy	  food	  intake.	  	  Finally,	  we	  did	  not	  measure	  physical	  activity	  level	  in	  the	  subjects.	  It	  could	  be	  possible	  that	  the	  combination	  of	  decreased	  caloric	  restriction	  and	  physical	  activity	  would	  have	  resulted	  in	  increased	  weight	  loss	  and	  decreased	  BMI	  and	  Waist	  Circumference	  in	  our	  subjects,	  specifically	  the	  AA	  subjects.	  	  A	  long	  term	  weight	  loss	  study	  performed	  with	  AA	  and	  WA	  women	  found	  that	  AA	  had	  higher	  odds	  of	  achieving	  weight	  loss	  by	  decreasing	  calories	  and	  focusing	  on	  their	  fast	  food	  and	  soft	  drink	  consumption.	  	  This	  study	  also	  noted	  that	  physical	  activity	  was	  a	  large	  factor	  in	  achieving	  long-­‐term	  weight	  loss	  rather	  than	  regaining	  the	  weight	  after	  a	  5-­‐year	  period	  [45].	  	  In	  addition,	  we	  believe	  that	  if	  our	  study	  was	  expanded	  to	  1	  year	  or	  more,	  we	  would	  have	  seen	  a	  more	  remarkable	  weight	  loss	  in	  our	  subjects.	  	  Finally,	  we	  did	  not	  measure	  physical	  activity	  level	  in	  the	  subjects,	  although	  the	  importance	  of	  physical	  activity	  was	  discussed	  as	  a	  part	  of	  the	  Comprehensive	  Weight	  Management	  program	  we	  did	  not	  accurately	  perform	  any	  measure	  of	  physical	  activity.	  	  It	  is	  possible	  that	  better	  results	  would	  have	  been	  achieved	  if	  this	  was	  incorporated	  at	  part	  of	  the	  program.	  	  In	  the	  Diabetes	  Prevention	  Program,	  we	  saw	  positive	  results	  of	  physical	  activity	  and	  weight	  loss	  when	  we	  looked	  at	  the	  Diabetes	  Prevention	  Program	  [42,43],	  and	  the	  Look	  Ahead	  Trial	  [29].	  Previous	  studies	  have	  also	  shown	  that	  physical	  activity	  greatly	  impacts	  weight	  loss,	  cholesterol	  concentrations,	  and	  inflammatory	  markers	  [38].	  	  Including	  a	  physical	  activity	  factor	  into	  our	  study	  could	  have	  also	  allowed	  us	  to	  see	  more	  significant	  changes	  in	  weight	  loss,	  body	  composition,	  and	  inflammatory	  markers,	  thus	  reducing	  multiple	  cardiovascular	  disease	  risk	  factors.	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